Skip to main content
. 2009 Jul 21;162(1):14–21. doi: 10.1016/j.jviromet.2009.07.001

Fig. 4.

Fig. 4

Time-dependent frequency changes of clinical samples in cell culture medium. (A) Frequency changes of clinical samples (without nanoparticles). (B) Frequency changes of clinical samples using nanoparticle-conjugated influenza A monoclonal antibody. (Inline graphic) 109 copies/mL, (–■–) 106 copies/mL, (Inline graphic) 105 copies/mL, (–▴–) 104 copies/mL, (Inline graphic) 103 copies/mL, and (Inline graphic) negative.

HHS Vulnerability Disclosure